Aveanna Healthcare Holdings, Inc. Stock Price, News & Analysis

Aveanna Healthcare (NASDAQ: AVAH) announced on October 21, 2025 that certain selling stockholders affiliated with J.H. Whitney Equity Partners VII have commenced a secondary offering of 10,000,000 shares of common stock, with underwriters granted a 30-day option to purchase up to an additional 1,500,000 shares.

The selling stockholders will receive all net proceeds; the company is not offering shares and will not receive any proceeds from the sale. Jefferies and J.P. Morgan are joint lead book-running managers; Barclays and RBC are bookrunners. A Form S-3 shelf registration (including a prospectus) has been filed and declared effective by the SEC.

Aveanna Healthcare (NASDAQ: AVAH) reported preliminary results for the three-month period ended September 27, 2025. Management expects revenue of $616M–$624M, up ~21.0%–22.6% year-over-year; net income of $11M–$15M, up ~125.7%–135.0% year-over-year; and Adjusted EBITDA of $77M–$81M, up ~61.0%–69.3% year-over-year.

Results are preliminary and unaudited, subject to closing procedures and potential material adjustments. The company disclosed significant non-GAAP adjustments, including $15.7M–$16.9M of fees related to debt modifications and various acquisition and integration costs.

Aveanna (NASDAQ: AVAH) will release its third quarter 2025 results before the market open on Thursday, November 6, 2025, followed by a conference call at 10:00 a.m. ET the same day.

Investors can join the live call by dialing 1-877-407-0789 (U.S.) or 1-201-689-8562 (international). A replay will be available three hours after the call by dialing 1-844-512-2921 (U.S.) or 1-412-317-6671 (international) using passcode 13755427. The telephone replay is available until November 13, 2025, and a simultaneous webcast and online replay will be hosted on the company Investor Relations website at https://ir.aveanna.com/.

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its management team will participate in the Deutsche Bank Annual Leveraged Finance Conference in Austin, TX on October 15, 2025. During the conference, the management will be available for one-on-one meetings with investors.

Aveanna Healthcare (Nasdaq: AVAH) has successfully completed a significant debt refinancing transaction. The company has refinanced its $886.0 million first lien term loans and secured $439.0 million in incremental first lien term loans, bringing the total to $1.325 billion with extended maturity to 2032.

Additionally, AVAH increased its revolving credit facility from $170.3 million to $250.0 million, extending its maturity to 2030. The company used the proceeds to fully repay its $415.0 million second lien term loans. Barclays Bank PLC and Jeffries Finance LLC acted as co-lead arrangers for the transaction.

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its participation in the upcoming Jefferies Healthcare Services Conference in Nashville on September 30, 2025. The company's management team will engage in one-on-one investor meetings and conduct a fireside chat at 3:00 PM Central Time.

Investors can access the fireside chat through a live webcast on Aveanna's Investor Relations website at ir.aveanna.com. A replay will be available for a limited time after the event.

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its management team's participation in the upcoming Deutsche Bank Healthcare Summit in New York on September 10, 2025. During the event, the management will conduct one-on-one meetings with investors.

Aveanna Healthcare Holdings (NASDAQ: AVAH), a leading home care platform, reported strong Q2 2025 financial results with significant growth across all divisions. Revenue increased 16.8% to $589.6 million, while net income surged 94.3% to $27.0 million. Adjusted EBITDA grew 93.6% to $88.4 million.

The company raised its full-year 2025 guidance, projecting revenue of over $2.3 billion (up from $2.15 billion) and Adjusted EBITDA of over $270 million (up from $207 million). The quarter was marked by the strategic acquisition of Thrive Skilled Pediatric Care, expanding Aveanna's market presence and core services.

As of June 28, 2025, Aveanna maintained a strong liquidity position with $100.7 million in cash and total available borrowing capacity of $253.3 million across its facilities.

Aveanna Healthcare (NASDAQ: AVAH) has scheduled its second quarter 2025 earnings release and conference call. The company will release results before market open on Thursday, August 7, 2025, followed by a conference call at 10:00 a.m. ET.

Investors can access the call via phone (1-877-407-0789 for US, 1-201-689-8562 for international) or webcast through the company's investor relations website. A replay will be available for one week with passcode 13754011.